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Background
HIV-1, the causative agent of the acquired immunodefi-
ciency syndrome (AIDS), infects CD4+ cells via interaction
with CD4 and either CCR5 or CXCR4 coreceptors (R5
and X4 viruses, respectively). However, only R5 virus
infection has pandemic proportions and it is efficiently
transmitted among individuals, either sexually, blood-
related or mother to child, whereas X4 viruses emerge
only in the late phase of the infection in association with
an advanced state of immunodeficiency and only, in ca.
50% of individuals infected with subtype B virus (dominant
in Europe, North America and Australia). Thus, unravel-
ling cellular and molecular correlates of this asymmetric
co-receptor use by HIV-1 would be relevant to better
understanding its pathogenesis and for developing preven-
tive strategies to block viral transmission.
Methods
We searched for meaningful gene expression profiles and
differences vs. uninfected cells (Mock) in primary human
cord blood CD4+ T lymphocytes (CBL) in which only
CCR5-dependent (R5), but not CXCR4-dependent (X4),
HIV-1 efficiently replicates [1]. The transcriptome of CBL
was established from 6 independent donors and examined
at different time points (8, 24, 48, 72 h) after infection by
isogenic NL4-3 (X4) and NL-AD8 (R5) viral strains differ-
ing only for their coreceptor use. We have performed sta-
tistical analysis of our multi-series time-course microarray
gene expression data using third degree polynomial and
backward regression strategy methods. We have also cross
compared our results with other similar studies and with
HIV-human protein-protein interaction data.
Results
Six and 73 genes were selectively mobilized by R5 and
X4 HIV-1 infection of CBL, respectively, while 21 genes
were modulated by both strains vs. control uninfected
cells. For the cross-comparison, we compared our find-
ings with those of different independent laboratories in
order to define genes peculiar to HIV infection and
commonly modulated in a statistically significant fash-
ion. Furthermore, from the HIV-human PPI datasets; we
observed 25 proteins among our significant human
genes interact directly with the HIV proteins and other
significant genes interact with the HIV proteins through
the different signalling pathways.
Conclusions
Thus, R5 and X4 HIV-1 infections profoundly affect the
transcriptional activity of primary CD4+ T lymphocytes.
We clearly demonstrated in this study that such an
asymmetry between the two strains is not due to differ-
ences in co-receptor expression on the cellular targets,
at least in vitro, or to a differential capacity of infecting
the cells by the two HIV strains.
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